Semaglutide, a glucagon-like peptide-1 receptor agonist, improves liver histology in MASH, but the underlying signals and pathways driving semaglutide-induced MASH resolution are not well understood
doi: 10.1073/pnas.2205785119 24 HansenCHWittstockUOlsenCEHickAJPickettJAHalkierBA
These two new approaches work somewhat differently
The 15mg maximum dose produced 20.9% average weight loss, establishing Tirzepatide as the benchmark for approved medications
What happens if you use Ozempic without diabetes
Spiller RC, Trotman IF, Higgins BE, Ghatei MA, Grimble GK, Lee YC et al